The largest community of pharma leaders

Infiniti’s Clinical Landscape Study Helped a Healthcare Company to Expand Treatment Portfolios Specific to Crohn’s Disease | RFP for Similar Engagements for Your Business

LONDON–()–Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of its latest success story on clinical landscape study for a US-based healthcare company.

Engagement Overview:

A healthcare company wanted to expand its treatment portfolio and offerings specific to Crohn’s disease. Also, they wanted to keep tabs on the design and progress of competitor trials in order to make informed decisions. Besides, the client wanted to optimize market access strategy, identify customers’ unmet needs, and review current treatment models. The client, therefore, chose to collaborate with Infiniti Research to leverage their expertise in offering clinical landscape study.

Other key objectives of the engagement were:

  • Objective 1: To assess unmet needs and corresponding opportunities
  • Objective 2: To understand how competing drugs are going through the development process
  • Objective 3: To gauge its progress against other companies in the US healthcare market

Want to identify current and potential treatment protocols, prescribing behaviors, and existing treatment therapies specific to Crohn’s disease. Request a FREE proposal here.

Our Approach:

The experts at Infiniti Research leveraged an existing database of physicians, HCPs, KOLs and patients in the target countries and deployed analyst team to identify additional contacts. Besides, 150+ primary interviews across different regions with the selected stakeholders were conducted to extract information about areas that are not covered in published sources. In addition to this, the experts developed key performance indicators (KPIs) to enable understanding of the focus areas.

Business impact of the clinical landscape study for the healthcare company

By partnering with Infiniti Research, the client was able to create pipeline profiles of players who are currently developing drugs for Crohn’s disease, understand how competing drugs are going through the development process, and improve the rate of success in qualifying for government grants.

By leveraging Infiniti’s clinical landscape study, the client was also able to:

  • Expand its treatment portfolios and offerings specific to Crohn’s disease across Canada, China, and Japan
  • Improve R&D productivity and make validation processes more efficient, resulting in cost savings
  • Understand patients’ multichannel behaviors and needs
  • Optimize market access strategy
  • Review current treatments

Want to gain more insights into our clinical landscape study for Crohn’s disease? Request more info here.

About Infiniti Research

Established in 2003, Infiniti Research, is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to help analyze competitive activity, see beyond market disruptions, and develop intelligent business strategies. To know more, visit:


Recent Articles